<DOC>
	<DOCNO>NCT01038167</DOCNO>
	<brief_summary>The purpose study evaluate effect telaprevir pharmacokinetics cyclosporine tacrolimus . Pharmacokinetics mean drug absorb bloodstream , distribute body eliminate body .</brief_summary>
	<brief_title>A Study Examine Effects Telaprevir Pharmacokinetics Cyclosporine Tacrolimus Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Healthy female ( nonchildbearing potential ) male subject 18 60 year age ( inclusive ) Body mass index ( BMI ) 18 30 kg/m2 ( inclusive ) Screening Visit Day 1 , weigh 50 kg Screening . History illness condition , opinion investigator , might confound result study pose additional risk administer study drug subject . Participated clinical study involve administration either investigational marketed drug within 2 month 5 halflives ( whichever longer ) Screening Visit . Positive result follow infectious disease test : hepatitis B antigen , hepatitis C virus antibody , human immunodeficiency virus 1 antibody , human immunodeficiency virus 2 antibody .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>VX-950</keyword>
</DOC>